signatur
altern
diagnost
method
standard
laboratori
clinic
paramet
routin
use
clinic
practic
aid
differenti
diagnosi
infect
sourc
evalu
entir
studi
cohort
bacteri
viral
noninfecti
evalu
paramet
includ
anc
neutrophil
lymphocyt
wbc
maxim
temperatur
accord
wellestablish
clinic
role
paramet
observ
statist
signific
differ
level
bacteri
viral
patient
fig
exampl
bacteri
patient
increas
level
anc
ttest
p
wbc
ttest
p
wherea
viral
patient
higher
lymphocyt
ttest
p
signatur
significantli
accur
individu
featur
ttest
p
combin
ttest
p
see
fig
figur
box
plot
clinic
paramet
laboratori
measur
bacteri
viral
noninfecti
patient
indic
entir
studi
cohort
bacteri
viral
noninfecti
red
line
circl
correspond
group
median
averag
respect
ttest
pvalu
bacteri
viral
group
infecti
bacteri
viral
vs
noninfecti
includ
healthi
subject
depict
signatur
outperform
clinic
paramet
protein
evalu
screen
phase
see
fig
follow
section
compar
signatur
select
protein
routin
use
clinic
set
immunolog
role
one
wide
use
use
protein
biomark
differenti
sepsi
noninfecti
caus
sir
critic
ill
patient
procalcitonin
pct
whether
pct
use
distinguish
local
bacteri
viral
infect
less
clear
test
measur
pct
concentr
randomli
select
patient
studi
cohort
n
bacteri
n
viral
randomli
select
patient
unanim
subcohort
n
bacteri
n
viral
compar
diagnost
accuraci
base
pct
level
signatur
pct
accuraci
calcul
use
standard
cutoff
routin
appli
clinic
set
ngml
ngml
ngml
ngml
maxim
pct
sensit
attain
cutoff
result
specif
unanim
subcohort
bacteri
viral
cohort
signatur
show
significantli
higher
sensit
p
specif
p
fig
comparison
use
patient
entir
studi
cohort
bacteri
viral
show
similar
result
fig
overal
despit
high
diagnost
prognost
valu
sepsi
detect
critic
ill
patient
result
indic
pct
less
accur
distinguish
patient
local
infect
bacteri
vs
viral
figur
comparison
perform
signatur
pct
use
differ
cutoff
perform
measur
patient
unanim
subcohort
bacteri
viral
b
perform
measur
patient
entir
studi
cohort
bacteri
viral
error
bar
repres
ci
signatur
sensit
specif
calcul
filter
patient
margin
immun
respons
anoth
protein
biomark
use
clinic
set
creactiv
protein
crp
acut
phase
respons
protein
upregul
infect
inflammatori
condit
compar
perform
crp
signatur
use
entir
studi
cohort
bacteri
viral
unanim
subcohort
bacteri
viral
crp
accuraci
determin
use
sever
standard
cutoff
appli
clinic
set
maxim
crp
sensit
attain
mgml
cutoff
result
specif
unanim
subcohort
bacteri
viral
fig
signatur
similar
sensit
significantli
higher
specif
p
cohort
similar
result
observ
use
entir
studi
cohort
bacteri
viral
fig
overal
signatur
similar
sensit
crp
mgl
cutoff
consider
higher
specif
distinguish
bacteri
viral
patient
next
examin
differenti
respons
protein
biomark
wellestablish
role
host
respons
infect
tabl
fig
biomark
test
least
patient
half
bacteri
half
viral
show
promis
result
test
addit
patient
patient
express
leukocyt
part
integrin
lymphocyt
functionassoci
play
central
role
leukocyt
intercellular
adhes
interact
ligand
icam
intercellular
adhes
molecul
also
function
lymphocyt
costimulatori
signal
member
cytokin
famili
pleiotrop
cytokin
involv
variou
immun
respons
inflammatori
process
hematopoiesi
produc
monocyt
macrophag
proprotein
proteolyt
process
releas
respons
cell
injuri
therebi
induc
apoptosi
cytokin
secret
mainli
macrophag
induc
cell
death
certain
tumor
cell
line
potent
pyrogen
caus
fever
directli
stimul
secret
potent
mediat
inflammatori
immun
respons
produc
activ
b
lymphocyt
involv
regul
variou
biolog
process
includ
cell
prolifer
differenti
apoptosi
lipid
metabol
coagul
neurotransmiss
trem
trem
proinflammatori
amplifi
present
neutrophil
monocyt
sinc
biomark
wellestablish
cutoff
clinic
set
use
auc
basi
comparison
fig
inform
biomark
trem
auc
accuraci
trem
significantli
lower
signatur
p
compar
two
auc
fig
result
demonstr
mere
particip
protein
host
respons
infect
necessarili
impli
diagnost
util
exampl
although
wellestablish
role
immun
respons
virus
intracellular
bacteria
short
halflif
h
limit
diagnost
util
concentr
blood
highli
depend
time
infect
onset
